TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Migraine DisordersMigraine, Acute
Interventions
DRUG

TREXIMET®

Sumatriptan + Naproxen Sodium (fixed dose combination tablet of sumatriptan succinate \[equivalent to sumatriptan 85mg\] and naproxen sodium 500mg)

DRUG

Butalbital-containing Combination Medications (BCM)

butalbital-containing combination medication (BCM; acetaminophen 325mg, caffeine 40mg, and butalbital 50mg) \[currently marketed as Fioricet\]

DRUG

placebo

placebo

Trial Locations (107)

10021

GSK Investigational Site, New York

10022

GSK Investigational Site, New York

10461

GSK Investigational Site, The Bronx

10550

GSK Investigational Site, Mount Vernon

11235

GSK Investigational Site, Brooklyn

11580

GSK Investigational Site, Valley Stream

12205

GSK Investigational Site, Albany

12206

GSK Investigational Site, Albany

12308

GSK Investigational Site, Schenectady

13210

GSK Investigational Site, Syracuse

14127

GSK Investigational Site, Orchard Park

15236

GSK Investigational Site, Pittsburgh

15601

GSK Investigational Site, Greensburg

19107

GSK Investigational Site, Philadelphia

19114

GSK Investigational Site, Philadelphia

21208

GSK Investigational Site, Pikesville

23452

GSK Investigational Site, Virginia Beach

27103

GSK Investigational Site, Winston-Salem

27518

GSK Investigational Site, Cary

27858

GSK Investigational Site, Greenville

28204

GSK Investigational Site, Charlotte

28401

GSK Investigational Site, Wilmington

28601

GSK Investigational Site, Hickory

29412

GSK Investigational Site, Charleston

29681

GSK Investigational Site, Simpsonville

29902

GSK Investigational Site, Beaufort

30024

GSK Investigational Site, Suwanee

30165

GSK Investigational Site, Rome

30309

GSK Investigational Site, Atlanta

30342

GSK Investigational Site, Atlanta

31406

GSK Investigational Site, Savannah

32117

GSK Investigational Site, Daytona Beach

32720

GSK Investigational Site, DeLand

33024

GSK Investigational Site, Pembroke Pines

33324

GSK Investigational Site, Plantation

33755

GSK Investigational Site, Clearwater

34102

GSK Investigational Site, Naples

37203

GSK Investigational Site, Nashville

38018

GSK Investigational Site, Cordova

38139

GSK Investigational Site, Germantown

38401

GSK Investigational Site, Columbia

39401

GSK Investigational Site, Hattiesburg

42003

GSK Investigational Site, Paducah

43210

GSK Investigational Site, Columbus

44122

GSK Investigational Site, Cleveland

45227

GSK Investigational Site, Cincinnati

45245

GSK Investigational Site, Cincinnati

45406

GSK Investigational Site, Dayton

46256

GSK Investigational Site, Indianapolis

48104

GSK Investigational Site, Ann Arbor

49009

GSK Investigational Site, Kalamazoo

57702

GSk Investigational Site, Rapid City

58104

GSK Investigational Site, Fargo

58501

GSK Investigational Site, Bismarck

58704

GSK Investigational Site, Minot

60031

GSK Investigational Site, Gurnee

60153

GSK Investigational Site, Maywood

60614

GSK Investigational Site, Chicago

63141

GSK Investigational Site, St Louis

65807

GSK Investigational Site, Springfield

71101

GSK Investigational Site, Shreveport

71103

GSK Investigational Site, Shreveport

72201

GSK Investigational Site, Little Rock

72205

GSK Investigational Site, Little Rock

73112

GSK Investigational Site, Oklahoma City

75231

GSK Investigational Site, Dallas

75234

GSK Investigational Site, Dallas

77004

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78258

GSK Investigational Site, San Antonio

78745

GSK Investigational Site, Austin

80909

GSK Investigational Site, Colorado Springs

84107

GSK Investigational Site, Salt Lake City

85014

GSK Investigational Site, Phoenix

85213

GSK Investigational Site, Mesa

85224

GSK Investigational Site, Chandler

85234

GSK Investigational Site, Gilbert

85283

GSK Investigational Site, Tempe

85340

GSK Investigational Site, Litchfield Park

87108

GSK Investigational Site, Albuquerque

89014

GSK Investigational Site, Henderson

89119

GSK Investigational Site, Las Vegas

90404

GSK Investigational Site, Santa Monica

91325

GSK Investigational Site, Northridge

91361

GSK Investigational Site, Westlake Village

91403

GSK Investigational Site, Sherman Oaks

92108

GSK Investigational Site, San Diego

92501

GSK Investigational Site, Riverside

92585

GSK Investigational Site, Sacramento

92618

GSK Investigational Site, Irvine

92660

GSK Investigational Site, Newport Beach

92801

GSK Investigational Site, Anaheim

92805

GSk Investigational Site, Anaheim

92845

GSK Investigational Site, Garden Grove

94109

GSK Investigational Site, San Francisco

94596

GSK Investigational Site, Walnut Creek

06118

GSK Investigational Site, East Hartford

06050

GSK Investigational Site, New Britain

33407-2450

GSK Investigational Site, West Palm Beach

04005

GSK Investigational Site, Biddeford

02301

GSk Investigational Site, Brockton

01104

GSK Investigational Site, Springfield

08002

GSK Investigational Site, Cherry Hill

07550

GSK Investigational Site, Ridgewood

08084

GSK Investigational Site, Stratford

43614-5809

GSK Investigational Site, Toledo

02886

GSK Investigational Site, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00573170 - TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults | Biotech Hunter | Biotech Hunter